-
Signature
-
/s/ James R. Gruber
-
Issuer symbol
-
ETON
-
Transactions as of
-
03 Feb 2026
-
Net transactions value
-
+$132,600
-
Form type
-
4
-
Filing time
-
05 Feb 2026, 17:18:48 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| RIEDEL NORBERT G |
Director |
C/O ETON PHARMACEUTICALS, INC., 21925 W. FIELD PARKWAY, SUITE 235, DEERPARK |
/s/ James R. Gruber |
05 Feb 2026 |
0001161662 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ETON |
Common Stock |
Exercise of in-the-money or at-the-money derivative security |
$132,600 |
+30,000 |
+600% |
$4.42 |
35,000 |
03 Feb 2026 |
Direct |
|
| holding |
ETON |
Common Stock |
|
|
|
|
|
157,145 |
03 Feb 2026 |
By Trust |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ETON |
Employee Stock Option (Right to Buy) |
Exercise of in-the-money or at-the-money derivative security |
$0 |
-30,000 |
-100% |
$0.000000 |
0 |
03 Feb 2026 |
Common Stock |
30,000 |
$4.42 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.